Risperdal Side Effects

Clinical studies have linked Risperdal to Gynecomastia in teenage boys. Risperidone, which is marketed under the brand name Risperdal, has been widely used throughout the U.S. If you suffered from gynecomastia after taking Risperdal, contact our law office for a consultation. You may be entitled to damages for emotional suffering, physical pain, and medical expenses. Our Risperdal lawsuit injury lawyers are accepting Risperdal lawsuits in all 50 states and Washington D.C. and can review your claim and provide you with legal advice on how to obtain compensation for your injury. Read on to learn more about the side effects of Risperdal and how our Risperdal injury lawyers can help you.

Risperdal Lawsuits Overview

Risperdal, manufactured by Janssen Pharmaceuticals, is used to treat schizophrenia and psychotic disorders. Risperdal belongs to a class of medicine called atypical antipsychotics. The drug helps restore the balance of certain chemical substances in the brain that cause disorganized thinking and negative moods. The Food and Drug Administration (FDA) approved the drug in 2002 to treat schizophrenia in adults and teenagers. Doctors have prescribed the drug to treat mania and depression and alleviate autism symptoms. Common side effect of Risperdal includes the following:

  • Constipation and diarrhea
  • Anxiety
  • Nausea and vomiting
  • Restlessness
  • Muscle or joint pain

In some cases, Risperdal has been known to cause serious side effects. These side effects have led to a surge in Risperdal lawsuits across the United States. In particular, new research shows that teenage boys and older men suffer from gynecomastia after taking Risperdal. Gynecomastia results from a decrease of testosterone in comparison to estrogen. With a decreased amount of testosterone in the body and an increased amount of prolactin (a hormone that stimulates healthy breasts to develop in teenage girls), teenage boys are exposed to an increased risk of growing breasts when taking Risperdal. The breasts may become tender, and only one may grow. This results in teenage boys having uneven breasts that can only be removed surgically. Mild forms of gynecomastia can be treated with liposuction.

Enlarged breasts in teenage boys can cause psychological and emotional trauma. Teenage boys may feel embarrassed by their physical appearance as well. Research has shown that increased levels of prolactin can last for up to two years after taking Risperdal.

If you are currently taking Risperdal and suffer from abnormal breast growth, contact your doctor. You should also contact your doctor if you experience breast swelling, pain, tenderness, and nipple discharge. Your doctor can review your condition and prescribe a new medication. Do not stop taking Risperdal without first consulting with your healthcare provider. If you suffer from gynecomastia, you may be entitled to compensation. Do not delay in contacting an attorney. The statute of limitations bars recovery if a patient delays in filing a claim.

Patients have argued that Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson, failed to warn patients of the dangers of developing Gynecomastia after taking Risperdal. Johnson & Johnson has been ordered to pay substantial settlements for improperly marketing Risperdal for unapproved uses and paying kickbacks to doctors and nurses. No class action has been filed to date against Johnson & Johnson. Our team of Risperdal lawsuit attorneys are currently reviewing Risperdal lawsuits for damages. Contact our personal injury attorneys handling Risperdal lawsuits for a free consultation.

Regardless of where you were injured our team or mass tort attorneys can help as they serve all 50 states and Washington D.C. including: Alabama, Alaska, Arkansas, California, Colorado, Connecticut, Delaware, Florida, Georgia, Hawaii, Idaho, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Carolina, South Dakota, Tennessee, Texas, Utah, Vermont, Virginia, Washington, Washington D.C., West Virginia, Wyoming and Wisconsin.